Research programme: non-nucleoside reverse transcriptase inhibitors - NumerateAlternative Names: NNRTIs programme - Numerate
Latest Information Update: 16 Jul 2016
At a glance
- Originator Numerate
- Class Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in HIV-infections in USA
- 03 Mar 2008 Early research in HIV infections in USA (unspecified route)